Skip to main content
Caplight Logo









S3V Vascular Technologies

S3V Vascular Technologies

Private
MysuruHealthcare & Life Scienceshttp://s3vvascular.com/

Last Round

Series B

Mar 14, 2024

Total Funding Raised

$43.52M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

S3V Vascular Technologies is a medical devices company that develops, manufactures, and markets minimally invasive cardiovascular, neurovascular, and critical-care medical devices.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

medical device manufacturingminimally invasive devicesmedtechinterventional devicescardiovascular devicesdrug-eluting stentsneurovascular devicesmechanical thrombectomymade in India medical devicesaffordable medical devicesballoon catheterstroke treatmenttranscatheter aortic valve replacementTAVRmedical device contract manufacturing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

S3V Vascular Technologies Comparables

Compare S3V Vascular Technologies with similar companies based on industry and business-model similarity.

S3V Vascular Technologies comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Relisys Medical Devices
86%
Translumina Therapeutics
84%
Sahajanand Medical Technologies Limited
83%

S3V Vascular Technologies Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BMar 14, 2024
Series AJul 1, 2022
DebtMay 9, 2017
SeedAug 9, 2011

S3V Vascular Technologies Investors

Notable investors and investment history

S3V Vascular Technologies investors
InvestorRounds
Jain International Trade OrganisationSeries A
Technology Development BoardDebt, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 1, 2026

    Open roles increased to 16, 13% of headcount.

  • Jul 13, 2026

    Open roles increased to 16, 5.3x the trailing average.

S3V Vascular Technologies Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

S3V Vascular Technologies Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about S3V Vascular Technologies's valuation, stock price, and market status.

Firmographic Details

HeadquartersMysuru
Employee Range123
Year Founded2011
Last FundingMar 14, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?